2019
DOI: 10.1101/716662
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Pathogenic and uncertain genetic variants have clinical cardiac correlates in diverse biobank participants

Abstract: Background: Genome sequencing coupled with electronic heath record data can uncover medically important genetic variation. Interpretation of rare genetic variation and its role in mediating cardiovascular phenotypes is confounded by variants of uncertain significance. Methods and Results:We analyzed the whole genome sequence of 900 racially and ethnically diverse biobank participants selected from a single US center. Participants were equally divided among European, African, Hispanic, and mixed race/ethnicitie… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
11
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
4
2

Relationship

1
5

Authors

Journals

citations
Cited by 9 publications
(11 citation statements)
references
References 37 publications
0
11
0
Order By: Relevance
“…22 Since VOUS CNVs should not be considered benign, we classified CNVs into two groups: abnormal CNVs (abnormal CNVs), defined as pathogenic CNVs (including aneuploidy) or VOUS, and normal CNVs (normal CNVs), defined as no CNVs > 500 kb or benign CNVs. [23][24][25] . As such, the abnormal CNVs and normal CNVs groups were compared in statistical analysis.…”
Section: Methodsmentioning
confidence: 99%
“…22 Since VOUS CNVs should not be considered benign, we classified CNVs into two groups: abnormal CNVs (abnormal CNVs), defined as pathogenic CNVs (including aneuploidy) or VOUS, and normal CNVs (normal CNVs), defined as no CNVs > 500 kb or benign CNVs. [23][24][25] . As such, the abnormal CNVs and normal CNVs groups were compared in statistical analysis.…”
Section: Methodsmentioning
confidence: 99%
“…Achieving this goal relies critically on developing the capability to recognize the one or a few mutations that have a clinical impact among the hundreds of thousands of benign variants which are normally present in an individual's genome. 18,19 Next generation sequencing (NGS) is now being applied routinely in clinical diagnostic settings, 20 making the prediction of pathogenic DNA variants, and particularly of missense variants, a crucial element not only for medical research, but also in the context of patient diagnosis and disease management. The American College of Medical Genetics and Genomics (ACMG) has provided guidelines for the classification of variants into five categories: pathogenic, likely pathogenic, variants of uncertain significance (VUSs), likely benign, and benign, thereby establishing a terminology that has been widely adopted by the molecular genetics community.…”
Section: Introductionmentioning
confidence: 99%
“…Analysis of cardiomyopathy testing at the Laboratory for Molecular Medicine revealed a lower likelihood of detecting a likely pathogenic or pathogenic variant—and a higher likelihood of a VUS—in individuals of African ancestry [ 75 ]. Furthermore, in individuals of African and Latino ancestry, VUSs in medically actionable cardiomyopathy genes are associated with clinical findings such as increased left ventricular diameter in systole and diastole [ 76 ]. As described above in a single DCM referral center, TTN truncating variants were enriched in individuals of European ancestry but not in individuals of African ancestry; reasons for this unexpected observation require further study [ 47 ].…”
Section: Emerging Concepts In Dcm Genetic Testingmentioning
confidence: 99%